Design space development for lyophilization using Doe and process modeling

BioPharm International

Volumn 23, Issue 9, 2010, Pages 26-36

  Sundaram, Jagannathan ^a   Shay, Yun Hua Max ^a   Hsu, Chung C ^a   Sane, Samir U ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ANTIBODY PRODUCTION; ARTICLE; EQUIPMENT DESIGN; FREEZE DRYING; LOW TEMPERATURE PROCEDURES; MATHEMATICAL MODEL; PROCESS MODEL; PRODUCT DEVELOPMENT; RISK ASSESSMENT; SAFETY;

EID: 78650324206     PISSN: 1542166X     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (15)

1. Rathore AS. A roadmap for implementation of Quality by Design (QbD) for biotechnology products. Trends Biotechnol. 2009;27(9):546-53.
2. US Food and Drug Administration. Guidance for industry. Q8 (R2). Pharmaceutical development. Rockville, MD; Nov. 2009.
3. Horvath B, Mun M, Laird MW. Characterization of a monoclonal antibody cell culture production process using a quality by design approach. Mol Biotechnol. 2010;45(3):203-6.
4. Ng K, Rajagopalan N. Application of quality by design and risk assessment principles for the development of formulation design space. In: Rathore AS, Mhatre R, editors. Quality by design for biopharmaceuticals: perspectives and case studies. Hoboken, NJ: John Wiley & Sons; 2009.
5. Xie L, Wu H, Shen M, Augsberger LL, Lyon RC, Khan MA, Hussain AS, Hoag SW. Quality-bydesign (QbD): Effects of testing parameters and formulation variables on the segregation tendency of pharmaceutical powder measured by the ASTM D 6940-04 segregation tester. J Pharm Sci. 2008;97(10):4485-97.
6. Hsu CC, Walsh AJ, Nguyen HM, Overcashier DE, Koning-Bastiaan H, Bailey RC, Nail SL. Design and application of a low-temperature Peltier-cooling microscope stage. J Pharm Sci. 1996;85(1):70-4.
7. Oetjen GW, Haseley P. Freeze-drying. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co.; 2004.
8. Pikal MJ. Freeze-drying of proteins, Part I; process design, BioPharm Int. 1990;3:18-28.
9. Chang BS, Fischer NL. Development of an efficient single-step freeze-drying cycle for protein formulations. Pharm Res. 1995;12(6):831-7.
10. Lim F, Martin-Moe, S, Sane SU. IBC USA Conferences Inc. A holistic approach to drug product process characterization and validation for a monoclonal antibody using QbD concepts. Process and Product Validation Event. Carlsbad, CA. 2010 Mar. 1-2.
11. Nail, SL, Searles JA. Elements of quality by design in development of freeze-dried parenterals, BioPharm Int. 2008;21(1):44-52.
12. Sane SU, Hsu CC. Considerations for successful lyophilization process scale-up, technology transfer and routine production. In: Jameel F, Hershenson S, editors. Formulation and process development strategies for manufacturing biopharmaceuticals. Hoboken, NJ: John Wiley & Sons, Inc.; 2010.
13. Sane SU, Hsu CC. A mathematical model for a large-scale freeze-drying process: a tool for process development & efficient production. Proceedings of 16th International Drying Symposium, Hyderabad, India. 2008; pp. 680-8.
14. Overcashier DE, Patapoff TW, Hsu CC. Lyophilization of protein formulations in vials: Investigation of the relationship between resistance to vapor flow during primary drying and small-scale product collapse. J Pharm Sci. 1999;88(7):688-95.
15. Pikal MJ, Shah S, Senior D, Lang JE. Physical chemistry of freeze-drying: measurement of sublimation rates for frozen aqueous solutions by microbalance technique. J Pharm Sci. 1983;72(6):635-50.